Connection

SHINYA YAMAMOTO to Pyridazines

This is a "connection" page, showing publications SHINYA YAMAMOTO has written about Pyridazines.
Connection Strength

0.237
  1. Focal Segmental Sclerosis Associated with the Novel Multi-tyrosine Kinase Inhibitor Ponatinib. Intern Med. 2023 Sep 15; 62(18):2693-2698.
    View in: PubMed
    Score: 0.186
  2. Effects of focal cortical cooling on somatosensory evoked potentials in rats. Brain Res. 2024 Oct 01; 1840:148995.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.